Back to Search
Start Over
Inhibition of histamine release from human basophils in vitro by calmodulin antagonists.
- Source :
-
Clinical immunology and immunopathology [Clin Immunol Immunopathol] 1983 Sep; Vol. 28 (3), pp. 334-40. - Publication Year :
- 1983
-
Abstract
- Calmodulin is a ubiquitous and versatile Ca2+-binding protein that plays a pivoting role in cellular metabolism. We have investigated the possibility that calmodulin plays a role in immediate hypersensitivity reactions by evaluating the effects of two agents, trifluoperazine dihydrochloride (TFP) and the sulfonamide derivative N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide (W-7) which selectively bind to calmodulin. TFP and W-7 cause a dose-dependent inhibition of histamine secretion from human basophils in vitro induced by several immunological (i.e., antigen and anti-IgE) and nonimmunological (i.e., formyl-methionine-containing peptide and the Ca2+ ionophore A23187) stimuli. These results indicating that two specific calmodulin antagonists are potent inhibitors of the secretory response of human basophils support the hypothesis that calmodulin may play a role in the control of the release of preformed mediators from human inflammatory cells.
- Subjects :
- Adult
Basophils immunology
Binding Sites
Dose-Response Relationship, Drug
Humans
Sulfonamides pharmacology
Trifluoperazine pharmacology
Basophils drug effects
Calcium-Binding Proteins antagonists & inhibitors
Calmodulin antagonists & inhibitors
Histamine Release drug effects
Immunosuppressive Agents pharmacology
Subjects
Details
- Language :
- English
- ISSN :
- 0090-1229
- Volume :
- 28
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Clinical immunology and immunopathology
- Publication Type :
- Academic Journal
- Accession number :
- 6192958
- Full Text :
- https://doi.org/10.1016/0090-1229(83)90100-9